Board MeetingOutcome of Board Meeting

Alkem Laboratories' board approved Q1FY27 consolidated financial results.

Alkem Laboratories Limited logo
Alkem Laboratories LimitedALKEM · Filed with the exchange

Revenue from operations hit ₹3,740.15 Cr, with net profit at ₹519.96 Cr (EPS ₹43.49). Post-quarter, the company acquired a majority stake in Occlutech Holding AG, Switzerland.

Read the original filing(PDF)

No comments yet. Be the first.

More from Alkem Laboratories Limited

All announcements